| 000 | 01309 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515185704.0 | ||
| 264 | 0 | _c20100330 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1872-9061 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBhat, S A | |
| 245 | 0 | 0 |
_aNovel antibodies in the treatment of non-Hodgkin's lymphoma. _h[electronic resource] |
| 260 |
_bThe Netherlands journal of medicine _cSep 2009 |
||
| 300 |
_a311-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntigens, CD _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCD2 Antigens _ximmunology |
| 650 | 0 | 4 |
_aCD40 Antigens _ximmunology |
| 650 | 0 | 4 | _aCD52 Antigen |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aGlycoproteins _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aKi-1 Antigen _ximmunology |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aRituximab |
| 700 | 1 | _aCzuczman, M S | |
| 773 | 0 |
_tThe Netherlands journal of medicine _gvol. 67 _gno. 8 _gp. 311-21 |
|
| 999 |
_c19164882 _d19164882 |
||